Personal information

Websites & social links

Twitter

Countries

United Kingdom

Activities

Collapse all

Employment (1)

University of Oxford: Oxford, Oxfordshire, GB

(Medical Sciences Office)
Employment
Source: check_circle
ORCID Integration at the University of Oxford

Education and qualifications (2)

Imperial College London: London, Westminster, GB

2016-10-01 to 2022-07-10 | MBBS Medicine (School of Medicine)
Education
Source: Self-asserted source
Junzheng Wang

Imperial College London: London, Westminster, GB

2019-10-01 to 2020-06-26 | BSc Medical Sciences with Global Health (School of Public Health)
Education
Source: Self-asserted source
Junzheng Wang

Works (10)

Lenacapavir to prevent HIV infection: current prices versus estimated costs of production

Journal of Antimicrobial Chemotherapy
2024-11-04 | Journal article
DOI: 10.1093/jac/dkae305
Contributors: Andrew Hill; Jacob Levi; Cassandra Fairhead; Victoria Pilkington; Junzheng Wang; Madison Johnson; Jevon Layne; David Roberts; Joseph Fortunak
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Estimated minimum prices and lowest available national prices for antiobesity medications: Improving affordability and access to treatment

Obesity
2023-05 | Journal article
DOI: 10.1002/oby.23725
SOURCE-WORK-ID:

1403337

PMID: 36815242
Part of ISSN: 1930-7381
WOSUID:

WOS:000936428900001
Contributors: Jacob Levi; Junzheng Wang; Francois Venter; Andrew Hill
Source: check_circle
Imperial College London
grade
Preferred source (of 2)‎

Current prices versus minimum costs of production for CFTR modulators

Journal of Cystic Fibrosis
2022-09-01 | Journal article
DOI: 10.1016/j.jcf.2022.04.007
SOURCE-WORK-ID:

1253091

PMID: 35440408
Part of ISSN: 1569-1993
WOSUID:

WOS:000935404300025
Contributors: Jonathan Guo; Junzheng Wang; Jingchun Zhang; Joseph Fortunak; Andrew Hill
Source: check_circle
Imperial College London
grade
Preferred source (of 2)‎

Barriers to Worldwide Access for Paxlovid, a New Treatment for COVID-19.

Open forum infectious diseases
2022-04-07 | Journal article
DOI: 10.1093/ofid/ofac174
PMID: 36176569
PMC: PMC9383702
Contributors: Toby Pepperrell; Ellis L; Wang J; Hill A
Source: Self-asserted source
Junzheng Wang
grade
Preferred source (of 2)‎

Minimum manufacturing costs, national prices, and estimated global availability of new repurposed therapies for coronavirus disease 2019

Open Forum Infectious Diseases
2022-01 | Journal article
DOI: 10.1093/ofid/ofab581
SOURCE-WORK-ID:

1241619

PMC: PMC8709896
PMID: 34988252
Part of ISSN: 2328-8957
WOSUID:

WOS:000744981900013
Contributors: Junzheng Wang; Jacob Levi; Leah Ellis; Andrew Hill
Source: check_circle
Imperial College London
grade
Preferred source (of 2)‎

Meta-analysis of Randomized Trials of Ivermectin to Treat SARS-CoV-2 Infection

Open Forum Infectious Diseases
2021-11-01 | Journal article
DOI: 10.1093/ofid/ofab358
Part of ISSN: 2328-8957
Source: Self-asserted source
Junzheng Wang
grade
Preferred source (of 2)‎

Minimum manufacturing costs, national prices and estimated global availability of new repurposed therapies for COVID-19

2021-06-03 | Other
DOI: 10.1101/2021.06.01.21258147
SOURCE-WORK-ID:

1403338
Contributors: Junzheng Wang; Jacob Levi; Leah Ellis; Andrew Hill
Source: check_circle
Imperial College London
grade
Preferred source (of 2)‎

The Essential Guide to the OSPE Assessments 2020

2020 | Book
SOURCE-WORK-ID:

1406073

ISBN: 9781527253902
Contributors: Junzheng Wang; Seungmin Han; Michal Kawka
Source: check_circle
Imperial College London

Minimum costs to manufacture new treatments for COVID-19.

Journal of virus eradication
2020-04-30 | Journal article
PMID: 32405423
PMC: PMC7213074
Source: Self-asserted source
Junzheng Wang
grade
Preferred source (of 2)‎

Review of safety and minimum pricing of nitazoxanide for potential treatment of COVID-19.

Journal of virus eradication
2020-04-30 | Journal article
PMID: 32405422
PMC: PMC7213070
Source: Self-asserted source
Junzheng Wang
grade
Preferred source (of 2)‎
How many people are using ORCID?